Publications
Sort:
Clinical Research Issue
Correlation of serum skeletal muscle-specific troponin T and myostatin with sarcopenia in the elderly
Chinese Journal of Multiple Organ Diseases in the Elderly 2026, 25(2): 118-123
Published: 28 February 2026
Abstract PDF (500.6 KB) Collect
Downloads:0
Objective

To investigate the association of serum skeletal muscle-specific troponin T (sTnT) and myostatin (MSTN) with geriatric sarcopenia.

Methods

After propensity score matching for sex and age, a retrospective analysis was conducted on 105 elderly inpatients admitted in our department between August 2022 and December 2024. Based on Asian Working Group for Sarcopenia (AWGS) criteria, the patients were categorized into a sarcopenia group (n = 41) and a non-sarcopenia group (n = 64). Clinical chara-cteristics and serum levels of sTnT and MSTN were compared between the two groups. R 4.3.0 and SPSS statistics 25.0 were used for statistical analysis. Data comparison between two groups was performed using t test, Mann Whitney U test, or Chi-square test depending on data type. Spearman correlation analysis was employed to investigate the correlation between sTnT and MSTN levels and factors related to sarcopenia. Multivariate logistic regression model was utilized to analyze the risk factors of sarcopenia in the elderly. Receiver operating characteristic (ROC) curve analysis was performed to assess the potential predictive values of serum sTnT, MSTN, and their combination for sarcopenia in the elderly.

Results

The sarcopenia group exhibited significantly lower body mass index and appendicular skeletal muscle mass index (ASMI), reduced albumin and triglycerides levels, decreased whole-body fat and muscle contents, smaller calf circumference, and lower grip strength and 6-meter walking speed, while higher scores of strength, assistance in walking, rise from a chair, climb stairs, falls combined with calf circumference questionnaire (SARC-CalF) and serum sTnT and MSTN levels when compared with the non-sarcopenia group (all P<0.001). In both male and female participants, the serum levels of sTnT and MSTN were negatively correlated with calf circumference and ASMI, and positively with SARC-CalF scores (all P<0.05). In the males, only sTnT was negatively correlated with grip strength (P=0.025), while in the females, both sTnT and MSTN levels were negatively correlated with grip strength (both P<0.001). There was no correlation between male sTnT and MSTN levels and 6-meter walking speed (both P>0.05), while only MSTN was negatively correlated with the speed in the females (P=0.039). Multivariate logistic regression analysis showed that sTnT (OR=1.03, 95%CI 1.01-1.05; P=0.028) and MSTN (OR=13.51, 95%CI 1.04-175.23, P=0.047) were independent risk factors for sarcopenia in the elderly. ROC curve analysis indicated that the area under the curve of sTnT and MSTN alone and in combination in predicting sarcopenia in the elderly were 0.93 (95%CI 0.87-0.99), 0.95 (95%CI 0.90-0.99) and 0.95 (95%CI 0.89-0.99), respectively.

Conclusion

Elevated sTnT and MSTN levels are closely associated with the development and progression of sarcopenia. The indicators alone or combined have potential predictive value for sarcopenia.

Total 1